GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Alere Inc (NYSE:ALRPRB.PFD) » Definitions » Scaled Net Operating Assets

Alere (ALRPRB.PFD) Scaled Net Operating Assets : 0.74 (As of Jun. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Alere Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Alere's operating assets for the quarter that ended in Jun. 2017 was $5,064.99 Mil. Alere's operating liabilities for the quarter that ended in Jun. 2017 was $883.82 Mil. Alere's Total Assets for the quarter that ended in Mar. 2017 was $5,673.87 Mil. Therefore, Alere's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2017 was 0.74.


Alere Scaled Net Operating Assets Historical Data

The historical data trend for Alere's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alere Scaled Net Operating Assets Chart

Alere Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.79 0.75 0.69 0.71

Alere Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.77 0.72 0.74 0.74

Competitive Comparison of Alere's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Alere's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alere's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Alere's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Alere's Scaled Net Operating Assets falls into.



Alere Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Alere's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2016 )
=(Operating Assets (A: Dec. 2016 )-Operating Liabilities (A: Dec. 2016 ))/Total Assets (A: Dec. 2015 )
=(5080.988-865.812)/5918.16
=0.71

where

Operating Assets(A: Dec. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5648.279 - 567.291
=5080.988

Operating Liabilities(A: Dec. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3816.672 - 2865.426 - 85.434
=865.812

Alere's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2017 )
=(Operating Assets (Q: Jun. 2017 )-Operating Liabilities (Q: Jun. 2017 ))/Total Assets (Q: Mar. 2017 )
=(5064.986-883.816)/5673.869
=0.74

where

Operating Assets(Q: Jun. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5556.835 - 491.849
=5064.986

Operating Liabilities(Q: Jun. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3791.262 - 2820.775 - 86.671
=883.816

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alere Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Alere's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Alere (ALRPRB.PFD) Business Description

Traded in Other Exchanges
N/A
Address
Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.
Executives
John Bridgen officer: Sr VP, Business Development 51 SAWYER ROAD, C/O INVERNESS MEDICAL INNOVATIONS INC, WALTHAM MA 02453
Geoffrey S Ginsburg director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Renuka Uppaluri officer: Senior VP, Global R&D 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Mark Gladwell officer: Senior VP, Global Operations 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Gregg J Powers director C/O QUANTUM CORPORATION, 224 AIRPORT PARKWAY SUITE 300, SAN JOSE CA 95110
Jonathan Wygant officer: VP, Controller, CAO 3750 TORREY VIEW COURT, SAN DIEGO X1 92130
Thomas Mckillop director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Melissa Guerdan officer: SVP, Global Quality & Reg. 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Daniella Cramp officer: Global Pres., Cardiometabolic 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Sanjay Malkani officer: Global Pres., Toxicology 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
James Jr. Roosevelt director 51 SAWYER ROAD, SUITE 200, HOPKINTON MA 02453
Robert Bernard Hargadon officer: SVP, Global Human Resources 4327 LAKE WASHINGTON BLVD NE #6208, KIRKLAND WA 98033
John F Levy director C/O INNVERNESS MEDICAL INNOVATIONS, INC., 51 SAWYER ROAD, WALTHAM MA 02453
John Quelch director C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYER RD, WALTHAM MA 02453
Carol R Goldberg director C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYERS RD, WALTHAM MA 02453

Alere (ALRPRB.PFD) Headlines

From GuruFocus

John Keeley Discloses Top New Stock Buys of Q2

By Holly LaFon Holly LaFon 09-17-2014

The Transformation in Alere

By Bavneet Singh Nagpal bavinagpal 05-22-2015

Diamond Hill Capital Comments on Alere Inc

By Vera Yuan Vera Yuan 03-17-2015

Corsair Capital's Analysis of Alere

By Canadian Value Canadian Value 03-06-2015

Shareholders Approve Alere, Abbott Merger

By Alberto Abaterusso Alberto Abaterusso 07-10-2017

Alere Inc.: Foreign Currency Translations and the Euro

By Carmine Romano Carmine Romano 12-21-2011

Diamond Hill Select Fund Third Quarter 2014 Commentary

By Vera Yuan Vera Yuan 10-17-2014

Alere Reports 2nd Quarter

By Alberto Abaterusso Alberto Abaterusso 08-04-2017